FDMT4D MOLECULAR THERAPEUTICS IN
CUSIP 35104E100 · common stock
2 tracked investors held 4D MOLECULAR THERAPEUTICS IN (FDMT) at the end of Q3 2026, worth $73.1M in total. The largest holder was RA Capital Management, with 0.7% of its portfolio.
Holders · Q3 2026
2
New holders
0
Value held
$73.1M
Quarter-end price (est.)
$14.31
Investors holding FDMT · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 0.72% | 5,049,779 | $72.3M | HOLD |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 58,546 | $837.8K | REDUCE-11.0% |